InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,184.11
(
0.07%
)
US TECH 100
17,603.80
(
-0.04%
)
Dow Jones
38,865.36
(
0.03%
)
Brent Oil
83.16
(
-0.38%
)
Bitcoin
63,199.08
(
0.05%
)

Replies to post #294 on Revance Therapeutics Inc (RVNC)

Replies to #294 on Revance Therapeutics Inc (RVNC)

DewDiligence

11/25/17 12:22 PM

#295 RE: Bickema #294

The expert in question especially likes RT002's safety profile—e.g. the low rate of dysphagia in the cervical dystonia trial.